Adjuvant Systemic Therapy in Older Breast Cancer Women: Can We Optimize the Level of Care?

by Anna Rachelle Mislang, Laura Biganzoli
Published 2015-07-01

Life Cycle Assessment of Reusable Plastic Crates (RPCs)

by Camilla Tua, Laura Biganzoli, Mario Grosso, Lucia Rigamonti
Published 2019-06-01

Managing advanced HR-positive, HER2-negative breast cancer with CDK4/6 inhibitors in post-menopausal patients: is there a best sequence?

by Lorenzo Rossi, Amelia McCartney, Emanuela Risi, Luca Malorni, Laura Biganzoli, Angelo Di Leo
Published 2018-12-01

The role of abemaciclib in treatment of advanced breast cancer

by Amelia McCartney, Erica Moretti, Giuseppina Sanna, Marta Pestrin, Emanuela Risi, Luca Malorni, Laura Biganzoli, Angelo Di Leo
Published 2018-05-01

Precision Oncology via NMR-Based Metabolomics: A Review on Breast Cancer

by Alessia Vignoli, Emanuela Risi, Amelia McCartney, Ilenia Migliaccio, Erica Moretti, Luca Malorni, Claudio Luchinat, Laura Biganzoli, Leonardo Tenori
Published 2021-04-01

Circulating Biomarkers of CDK4/6 Inhibitors Response in Hormone Receptor Positive and HER2 Negative Breast Cancer

by Ilenia Migliaccio, Angela Leo, Francesca Galardi, Cristina Guarducci, Giulio Maria Fusco, Matteo Benelli, Angelo Di Leo, Laura Biganzoli, Luca Malorni
Published 2021-05-01

Cell-Free DNA-Methylation-Based Methods and Applications in Oncology

by Francesca Galardi, Francesca De Luca, Dario Romagnoli, Chiara Biagioni, Erica Moretti, Laura Biganzoli, Angelo Di Leo, Ilenia Migliaccio, Luca Malorni, Matteo Benelli
Published 2020-12-01

A multi-stakeholder approach in optimising patients’ needs in the benefit assessment process of new metastatic breast cancer treatments

by Fatima Cardoso, Nils Wilking, Renato Bernardini, Laura Biganzoli, Jaime Espin, Kaisa Miikkulainen, Susanne Schuurman, Danielle Spence, Sabine Spitz, Sonia Ujupan, Nicole Zernik, Jenn Gordon
Published 2020-08-01

An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA project

by Giacomo Pelizzari, Grazia Arpino, Laura Biganzoli, Saverio Cinieri, Michelino De Laurentiis, Lucia Del Mastro, Angelo Di Leo, Stefania Gori, Valentina Guarneri, Paolo Marchetti, Fabio Puglisi
Published 2018-09-01

An RB-1 loss of function gene signature as a tool to predict response to neoadjuvant chemotherapy plus anti-HER2 agents: a substudy of the NeoALTTO trial (BIG 1-06)

by Emanuela Risi, Chiara Biagioni, Matteo Benelli, Ilenia Migliaccio, Amelia McCartney, Martina Bonechi, Cristina Guarducci, Florentine Hilbers, Serena Di Cosimo, Jens Huober, Dario Romagnoli, Giulia Boccalini, Stefania Vitale, Christos Sotiriou, Laura Biganzoli, Angelo Di Leo, Luca Malorni
Published 2019-12-01

Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Developmen...

by Maria Vittoria Dieci, Lucia Del Mastro, Michela Cinquini, Filippo Montemurro, Laura Biganzoli, Laura Cortesi, Alberto Zambelli, Carmen Criscitiello, Alessia Levaggi, Benedetta Conte, Massimo Calabrese, Alba Fiorentino, Caterina Marchiò, Corrado Tinterri, Veronica Andrea Fittipaldo, Giovanni Pappagallo, Stefania Gori
Published 2019-08-01

Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in...

by Lorenzo Rossi, Chiara Biagioni, Amelia McCartney, Ilenia Migliaccio, Giuseppe Curigliano, Giuseppina Sanna, Erica Moretti, Alessandro M. Minisini, Saverio Cinieri, Carlo Tondini, Grazia Arpino, Antonio Bernardo, Angelo Martignetti, Emanuela Risi, Marta Pestrin, Luca Boni, Matteo Benelli, Laura Biganzoli, Angelo Di Leo, Luca Malorni
Published 2019-05-01

Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial

by Francesca Galardi, Francesca De Luca, Chiara Biagioni, Ilenia Migliaccio, Giuseppe Curigliano, Alessandro M. Minisini, Martina Bonechi, Erica Moretti, Emanuela Risi, Amelia McCartney, Matteo Benelli, Dario Romagnoli, Silvia Cappadona, Stefano Gabellini, Cristina Guarducci, Valerio Conti, Laura Biganzoli, Angelo Di Leo, Luca Malorni
Published 2021-03-01

A Serum Metabolomics Classifier Derived from Elderly Patients with Metastatic Colorectal Cancer Predicts Relapse in the Adjuvant Setting

by Samantha Di Donato, Alessia Vignoli, Chiara Biagioni, Luca Malorni, Elena Mori, Leonardo Tenori, Vanessa Calamai, Annamaria Parnofiello, Giulia Di Pierro, Ilenia Migliaccio, Stefano Cantafio, Maddalena Baraghini, Giuseppe Mottino, Dimitri Becheri, Francesca Del Monte, Elisangela Miceli, Amelia McCartney, Angelo Di Leo, Claudio Luchinat, Laura Biganzoli
Published 2021-06-01

EFFECT: a randomized phase II study of efficacy and impact on function of two doses of nab-paclitaxel as first-line treatment in older women with advanced breast cancer

by Laura Biganzoli, Saverio Cinieri, Rossana Berardi, Rebecca Pedersini, Amelia McCartney, Alessandro Marco Minisini, Elena Rota Caremoli, Simon Spazzapan, Emanuela Magnolfi, Antonella Brunello, Emanuela Risi, Raffaella Palumbo, Silvana Leo, Marco Colleoni, Sara Donati, Sabino De Placido, Laura Orlando, Mirco Pistelli, Veronica Parolin, Anna Mislang, Dimitri Becheri, Fabio Puglisi, Giuseppina Sanna, Elena Zafarana, Luca Boni, Giuseppe Mottino
Published 2020-08-01

The requirements of a specialist breast centre

by Laura Biganzoli, Fatima Cardoso, Marc Beishon, David Cameron, Luigi Cataliotti, Charlotte E. Coles, Roberto C. Delgado Bolton, Maria Die Trill, Sema Erdem, Maria Fjell, Romain Geiss, Mathijs Goossens, Christiane Kuhl, Lorenza Marotti, Peter Naredi, Simon Oberst, Jean Palussière, Antonio Ponti, Marco Rosselli Del Turco, Isabel T. Rubio, Anna Sapino, Elzbieta Senkus-Konefka, Marko Skelin, Berta Sousa, Tiina Saarto, Alberto Costa, Philip Poortmans
Published 2020-06-01